trending Market Intelligence /marketintelligence/en/news-insights/trending/WcW-Yzrre-IUD1gHAWqb4Q2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Bionano Genomics prices $18M offering of common shares, warrants

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Bionano Genomics prices $18M offering of common shares, warrants

Bionano Genomics Inc. priced an underwritten offering of common shares and warrants to purchase common shares to raise about $18 million in gross proceeds.

The San Diego-based company is selling 20,937,558 common shares or prefunded warrants to purchase common shares, along with warrants to purchase the same number of common shares in the offering.

Each common share or prefunded warrant is being sold at 86 cents along with an accompanying warrant. For each prefunded warrant sold, the number of shares being offered by the company will decrease by one.

The common warrants will be immediately exercisable at the same price and will expire five years from the date of issuance.

Each warrant issued in the offering can be exercised for 86 cents to purchase a common share of Bionano for up to five years.

Bionano expects to close the offering on Oct. 23, subject to customary conditions.

The company plans to use proceeds for general corporate purposes, including working capital, sales and marketing activities. Funds raised will also support general and administrative matters and capital expenditures.

Oppenheimer & Co. Inc. is the sole book-running manager for the offering. Roth Capital Partners and Maxim Group LLC are lead and co-lead managers, respectively.